You must log in to view this webinar.

Second Chances: Real Life Challenges in Secondary Prevention of ASCVD

1.0 CME

After watching the webcast you will be automatically forwarded to the evaluation to earn your CME credits.


Nicole Ciffone, MSN, ANP-C, AAC, FNLA

Clinical Lipid Specialist

Arizona Center for Advanced Lipidology

Tucson, Arizona

Time of Talk

45 minutes

CME Accreditation

45 min webcast = 0.75 credits

15 min exam = 0.25 credits

Total = 1.0 credits


This talk will review the challenges of getting risk factors to goals for high risk and secondary prevention patients through case studies and guideline-supported medical management.

Learning Objectives

  1. Identify patients with a history of ASCVD who are at increased risk for recurrent events
  2. Review case studies of how guideline-based therapies could be applied
  3. Review currently available therapies with Cardiovascular Outcome Trials (CVOT) that have demonstrated benefit to reduce recurrent events
  4. Address important lifestyle considerations in management of patient to optimize care



  • Amarin
  • Amgen
  • Akcea
  • Astra Zeneca
  • Esperion

The AAFP has reviewed Cleveland HeartLab CME Webcasts, and deemed it acceptable for AAFP credit. Term of approval is from 04/05/2021 to 04/04/2022. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Credit approval includes the following session(s): 1.00 Enduring Materials, Self-Study AAFP Prescribed Credit(s) - Second Chances: Real Life Challenges in Secondary Prevention of ASCVD